Infliximab for the treatment of rheumatoid arthritis.
BACKGROUND: Infliximab is a human murine chimeric anti-tumour necrosis factor alpha monoclonal antibody recently approved for the treatment of refractory RA. OBJECTIVES: To assess the efficacy and safety of infliximab for the treatment of rheumatoid arthritis. SEARCH STRATEGY: Electronic databases...
Main Authors: | Blumenauer, B, Judd, M, Wells, G, Burls, A, Cranney, A, Hochberg, M, Tugwell, P |
---|---|
格式: | Journal article |
語言: | English |
出版: |
2002
|
相似書籍
-
Etanercept for the treatment of rheumatoid arthritis.
由: Blumenauer, B, et al.
出版: (2003) -
Etanercept for the treatment of rheumatoid arthritis
由: Blumenauer, B, et al.
出版: (2004) -
Etanercept for the treatment of rheumatoid arthritis.
由: Lethaby, A, et al.
出版: (2013) -
Infliximab in the treatment of rheumatoid arthritis
由: A Perdriger
出版: (2009-05-01) -
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
由: Jobanputra, P, et al.
出版: (2002)